tiprankstipranks
IO Biotech (IOBT)
NASDAQ:IOBT
US Market

IO Biotech (IOBT) Financial Statements

Compare
319 Followers

IO Biotech Financial Overview

IO Biotech's market cap is currently $62.26M. The company's EPS TTM is $-1.371; its P/E ratio is ―; IO Biotech is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is $-0.39. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -756.00K$ -540.00K$ 0.00$ 0.00$ 0.00
Operating Income$ -91.44M$ -71.42M$ -41.23M$ -10.14M$ -9.91M
EBITDA$ -91.23M$ -69.34M$ -67.45M$ 0.00$ -824.00K
Net Income$ -86.08M$ -71.46M$ -67.88M$ -12.07M$ -10.75M
Balance Sheet
Cash & Short-Term Investments$ 143.19M$ 142.59M$ 211.53M$ 3.40M$ 7.85M
Total Assets$ 150.72M$ 151.81M$ 222.29M$ 5.65M$ 9.42M
Total Debt$ 2.49M$ 2.79M$ 0.00$ 0.00$ 8.66M
Net Debt$ -140.70M$ -139.80M$ -211.53M$ -3.40M$ 817.00K
Total Liabilities$ 17.56M$ 12.95M$ 10.36M$ 40.96M$ 32.95M
Stockholders' Equity$ 133.16M$ 138.85M$ 211.92M$ -35.30M$ -23.53M
Cash Flow
Free Cash Flow$ -72.06M$ -60.42M$ -40.80M$ -9.96M$ -8.89M
Operating Cash Flow$ -71.74M$ -59.73M$ -40.65M$ -9.96M$ -8.89M
Investing Cash Flow$ -323.00K$ -690.00K$ -153.00K$ 0.00$ 0.00
Financing Cash Flow$ 71.86M$ 0.00$ 252.95M$ 5.10M$ 9.01M
Currency in USD

IO Biotech Earnings and Revenue History

IO Biotech Debt to Assets

IO Biotech Cash Flow

IO Biotech Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis